Title: Genetic strategies to bring islet xenotransplantation to the clinic
Authors: Hawthorne, WJ
Lew, AM
Thomas, HE
Issue Year: 2016
Publisher LIPPINCOTT WILLIAMS & WILKINS
Series Curr. Opin. Organ Transpl.:
Abstract Purpose of reviewDespite the benefits of islet and pancreas allotransplantation, their widespread use in type 1 diabetes is limited because of the paucity of suitable donors. Porcine xenotransplantation offers an alternative, and advances in genetic modification of pigs have opened up new potential for its clinical use. This review outlines the barriers to successful islet xenotransplantation, and genetic modifications that have been tested to overcome these.Recent findingsIslets from pigs lacking 1,3-galactosyltransferase, to prevent hyperacute rejection, are now used as a background strain for further genetic modifications. The instant blood-mediated inflammatory reaction is overcome by expressing complement regulators including CD46, CD55 and CD59. Prevention of immune-mediated rejection mediated by T cells, macrophages and natural killer cells remains a challenge. The use of immunosuppressive antibodies, such as anti-CD154 or anti-CD2, can be protective, and may be useful if they are produced by the islets themselves.SummaryThe field of xenotransplantation has benefited enormously from the development of new genetic modification strategies. With the possibility of multiple genetic modifications in the same animal, and a detailed knowledge of the mechanism of xenograft rejection, the challenge now is to develop islets that provide long-term graft survival without systemic immunosuppression.
URI: https://publications.svi.edu.au/publications/6512
Other Identifiers 10.1097/MOT.0000000000000353
Publication type Review